See more : Al Hassan Ghazi Ibrahim Shaker Company (1214.SR) Income Statement Analysis – Financial Results
Complete financial analysis of Indraprastha Medical Corporation Limited (INDRAMEDCO.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Indraprastha Medical Corporation Limited, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Nova Royalty Corp. (NOVR.V) Income Statement Analysis – Financial Results
- Geopulse Exploration, Inc. (GPLS) Income Statement Analysis – Financial Results
- Value Convergence Holdings Limited (0821.HK) Income Statement Analysis – Financial Results
- Swiss Life Holding AG (0QMG.L) Income Statement Analysis – Financial Results
- BayCom Corp (BCML) Income Statement Analysis – Financial Results
Indraprastha Medical Corporation Limited (INDRAMEDCO.BO)
About Indraprastha Medical Corporation Limited
Indraprastha Medical Corporation Limited provides hospital services in India. It offers services primarily in the areas of sugar, genomic medicine, elder care, anesthesiology, bariatric and metabolic surgery, bone marrow transplant, dental and cosmetic clinic, dermatology, dietetics and clinical nutrition, endovascular surgery, endocrinology, ENT, fetal medicine, laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, neonatology, nephrology, ophthalmology, pediatric sciences, urology, and surgery, physiotherapy and rehabilitation, psychiatry and clinical psychology, radiology and radio diagnosis, respiratory, rheumatology, spine surgery, urology and andrology, cardiology, oncology, emergency, gastroenterology, neurology/neurosurgery, orthopedics, robotic surgery, and transplant, as well as laboratory services, internal medicine, preventive health, sleep medicine and clinical care, and transfusion medicine. The company was founded in 1983 and is based in New Delhi, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12.45B | 10.65B | 8.62B | 5.96B | 7.97B | 7.60B | 7.24B | 7.29B | 7.33B | 6.93B | 6.60B | 5.91B | 5.03B | 4.35B | 4.24B | 3.91B | 3.15B | 2.33B |
| Cost of Revenue | 7.91B | 4.74B | 3.83B | 2.49B | 3.52B | 3.43B | 3.34B | 3.44B | 3.42B | 3.35B | 3.25B | 3.01B | 2.54B | 1.08B | 1.15B | 1.17B | 948.22M | 669.09M |
| Gross Profit | 4.54B | 5.91B | 4.79B | 3.47B | 4.44B | 4.18B | 3.90B | 3.85B | 3.90B | 3.58B | 3.35B | 2.90B | 2.49B | 3.28B | 3.10B | 2.74B | 2.20B | 1.66B |
| Gross Profit Ratio | 36.48% | 55.48% | 55.55% | 58.25% | 55.77% | 54.93% | 53.91% | 52.84% | 53.28% | 51.68% | 50.75% | 49.05% | 49.42% | 75.22% | 72.93% | 70.17% | 69.87% | 71.25% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 117.50M | 96.90M | 68.60M | 56.50M | 79.57M | 65.76M | 64.08M | 90.69M | 89.28M | 74.07M | 80.11M | 74.64M | 81.12M | 1.86B | 2.52B | 2.28B | 1.85B | 1.47B |
| Selling & Marketing | 1.04B | 889.80M | 533.50M | 264.40M | 489.62M | 433.97M | 387.63M | 386.69M | 372.76M | 363.20M | 334.15M | 260.57M | 172.60M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.16B | 986.70M | 602.10M | 320.90M | 569.19M | 499.73M | 451.71M | 477.38M | 462.05M | 437.26M | 414.26M | 335.21M | 253.71M | 1.86B | 2.52B | 2.28B | 1.85B | 1.47B |
| Other Expenses | 2.98B | 100.30M | 31.20M | 6.80M | 6.87M | -36.47M | 8.08M | 1.39M | 18.24M | 7.18M | 10.10M | 0.00 | 0.00 | 53.03M | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 4.13B | 4.78B | 3.94B | 3.40B | 3.90B | 3.65B | 3.47B | 3.36B | 3.45B | 3.01B | 2.72B | 2.36B | 2.02B | 2.84B | 2.59B | 2.31B | 1.88B | 1.39B |
| Cost & Expenses | 12.04B | 9.53B | 7.77B | 5.88B | 7.42B | 7.08B | 6.80B | 6.80B | 6.87B | 6.36B | 5.97B | 5.37B | 4.57B | 2.84B | 3.74B | 3.48B | 2.83B | 2.06B |
| Interest Income | 168.90M | 100.30M | 31.20M | 6.80M | 6.87M | 4.67M | 7.91M | 3.18M | 2.93M | 2.56M | 3.42M | 6.13M | 3.16M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 40.60M | 4.60M | 6.10M | 33.36M | 11.31M | 30.01M | 55.85M | 46.83M | 44.12M | 53.01M | 95.51M | 64.78M | 39.50M | 43.63M | 38.54M | 57.47M | 62.75M | 50.95M |
| Depreciation & Amortization | 400.80M | 392.70M | 349.40M | 333.23M | 329.69M | 297.54M | 306.82M | 305.32M | 353.25M | 281.76M | 281.43M | 258.91M | 218.27M | 216.03M | 192.90M | 186.68M | 161.71M | 135.61M |
| EBITDA | 2.07B | 1.61B | 1.17B | 409.48M | 870.78M | 812.46M | 721.99M | 792.55M | 814.96M | 858.30M | 918.48M | 778.50M | 657.88M | -2.84B | 696.97M | 616.69M | 482.70M | 402.33M |
| EBITDA Ratio | 16.65% | 14.82% | 13.96% | 6.43% | 10.46% | 10.37% | 9.90% | 10.50% | 10.94% | 12.08% | 13.92% | 13.29% | 13.20% | -65.26% | 16.42% | 15.76% | 15.34% | 17.15% |
| Operating Income | 1.56B | 1.13B | 857.90M | 84.78M | 458.06M | 435.01M | 359.09M | 376.55M | 437.40M | 555.94M | 637.05M | 526.99M | 445.58M | -3.06B | 504.07M | 430.01M | 320.99M | 263.43M |
| Operating Income Ratio | 12.51% | 10.62% | 9.95% | 1.42% | 5.75% | 5.72% | 4.96% | 5.16% | 5.97% | 8.02% | 9.65% | 8.91% | 8.86% | -70.22% | 11.88% | 10.99% | 10.20% | 11.32% |
| Total Other Income/Expenses | 104.20M | 40.30M | -67.20M | -41.89M | -62.44M | -78.28M | -94.83M | -79.99M | -69.76M | -78.79M | -85.41M | -87.45M | -61.39M | 163.75M | -38.54M | -57.47M | -62.75M | -33.71M |
| Income Before Tax | 1.66B | 1.17B | 790.70M | 42.90M | 481.92M | 446.21M | 340.05M | 408.18M | 387.46M | 495.47M | 541.54M | 454.81M | 400.10M | 452.68M | 465.53M | 372.53M | 258.24M | 229.72M |
| Income Before Tax Ratio | 13.35% | 11.00% | 9.17% | 0.72% | 6.05% | 5.87% | 4.70% | 5.60% | 5.29% | 7.14% | 8.20% | 7.69% | 7.95% | 10.40% | 10.97% | 9.52% | 8.21% | 9.87% |
| Income Tax Expense | 421.50M | 310.30M | 204.50M | 19.60M | 45.68M | 162.08M | 129.02M | 145.72M | 143.13M | 170.56M | 187.18M | 167.16M | 130.14M | 145.43M | 154.93M | 133.66M | 96.76M | 82.48M |
| Net Income | 1.24B | 861.50M | 586.20M | 23.30M | 436.24M | 284.13M | 211.03M | 262.45M | 244.33M | 324.91M | 354.36M | 287.65M | 269.96M | 307.25M | 310.60M | 238.87M | 161.48M | 147.24M |
| Net Income Ratio | 9.96% | 8.09% | 6.80% | 0.39% | 5.48% | 3.74% | 2.92% | 3.60% | 3.34% | 4.69% | 5.37% | 4.87% | 5.37% | 7.06% | 7.32% | 6.11% | 5.13% | 6.33% |
| EPS | 13.52 | 9.40 | 6.39 | 0.25 | 4.76 | 3.10 | 2.30 | 2.86 | 2.67 | 3.54 | 3.87 | 3.14 | 2.94 | 3.35 | 3.39 | 2.61 | 1.76 | 1.61 |
| EPS Diluted | 13.52 | 9.40 | 6.39 | 0.25 | 4.76 | 3.10 | 2.30 | 2.86 | 2.67 | 3.54 | 3.87 | 3.14 | 2.94 | 3.35 | 3.39 | 2.61 | 1.76 | 1.61 |
| Weighted Avg Shares Out | 91.67M | 91.67M | 91.67M | 91.67M | 91.67M | 91.67M | 91.67M | 91.67M | 91.67M | 91.67M | 91.57M | 91.67M | 91.67M | 91.67M | 91.67M | 91.67M | 91.67M | 91.67M |
| Weighted Avg Shares Out (Dil) | 91.67M | 91.67M | 91.67M | 91.67M | 91.67M | 91.67M | 91.67M | 91.77M | 91.67M | 91.67M | 91.57M | 91.67M | 91.67M | 91.67M | 91.67M | 91.67M | 91.67M | 91.67M |
Source: https://incomestatements.info
Category: Stock Reports